Development and characterisation of NKp44-based chimeric antigen receptors that confer T cells with NK cell-like specificity.
Yasushi KasaharaChansu ShinNobuhiro KuboKeichiro MiharaHaruko IwabuchiTakayuki TakachiMasaru ImamuraAkihiko SaitohChihaya ImaiPublished in: Clinical & translational immunology (2020)
NKp44-based CAR endows T cells with NK cell-like anti-tumor specificity. The CAR gene created in this study will be useful for the development of novel gene-modified T-cell immunotherapy.